- Home
- IMTE vs NLSP Comparison
IMTE vs NLSP Comparison
Compare IMTE & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMTE
- NLSP
- Stock Information
- Founded
- IMTE 2008
- NLSP 2015
- Country
- IMTE Malaysia
- NLSP Switzerland
- Employees
- IMTE N/A
- NLSP N/A
- Industry
- IMTE Consumer Electronics/Appliances
- NLSP Biotechnology: Pharmaceutical Preparations
- Sector
- IMTE Consumer Staples
- NLSP Health Care
- Exchange
- IMTE Nasdaq
- NLSP Nasdaq
- Market Cap
- IMTE 4.2M
- NLSP 6.9M
- IPO Year
- IMTE N/A
- NLSP 2021
- Fundamental
- Price
- IMTE $1.03
- NLSP $1.63
- Analyst Decision
- IMTE
- NLSP
- Analyst Count
- IMTE 0
- NLSP 0
- Target Price
- IMTE N/A
- NLSP N/A
- AVG Volume (30 Days)
- IMTE 5.0K
- NLSP 2.7M
- Earning Date
- IMTE 03-25-2025
- NLSP 10-18-2024
- Dividend Yield
- IMTE N/A
- NLSP N/A
- EPS Growth
- IMTE N/A
- NLSP N/A
- EPS
- IMTE N/A
- NLSP N/A
- Revenue
- IMTE $123,337.00
- NLSP N/A
- Revenue This Year
- IMTE N/A
- NLSP N/A
- Revenue Next Year
- IMTE N/A
- NLSP N/A
- P/E Ratio
- IMTE N/A
- NLSP N/A
- Revenue Growth
- IMTE 4.75
- NLSP N/A
- 52 Week Low
- IMTE $1.04
- NLSP $1.47
- 52 Week High
- IMTE $3.84
- NLSP $18.40
- Technical
- Relative Strength Index (RSI)
- IMTE 33.41
- NLSP 38.80
- Support Level
- IMTE $1.11
- NLSP $1.47
- Resistance Level
- IMTE $1.20
- NLSP $1.78
- Average True Range (ATR)
- IMTE 0.07
- NLSP 0.14
- MACD
- IMTE -0.01
- NLSP -0.02
- Stochastic Oscillator
- IMTE 6.90
- NLSP 18.39
About IMTE Integrated Media Technology Limited
Integrated Media Technology Ltd is engaged in the development, sale, and distribution of autostereoscopic 3D display, 3D conversion equipment, and software, development, and sale of 3D autostereoscopic technology, and the provision of 3D consultancy services. It operates through the following segments: the sale of electronic glass, sales of air-filter products, sales of Halal products, NFT, corporate, provision of consultancy and provision of new energy products and solutions.
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.